A novel device for the synthesis of carbazole Schiff base derivatives

The integrated synthesis apparatus addresses inefficiencies in conventional methods by automating temperature control and solvent management, ensuring precise and scalable production of carbazole Schiff base derivatives with improved yield and safety.

DE202025106756U1Active Publication Date: 2026-01-15LOVELY PROFESSIONAL UNIVERSITY PHAGWARA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE202025106756
Authority / Receiving Office
DE · DE
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2025-11-06
Publication Date
2026-01-15
Estimated Expiration
2035-11-30

AI Technical Summary

Technical Problem

Conventional laboratory methods for synthesizing carbazole Schiff base derivatives are labor-intensive, time-consuming, prone to temperature fluctuations, require separate apparatus for different steps, and lack integrated automation, leading to inefficiencies and reduced reproducibility.

Method used

A novel synthesis apparatus integrating modules for heating, reflux, condensation, and crystallization, with automated control of temperature, solvent management, and in-situ monitoring, enabling multi-step synthesis of carbazole Schiff base derivatives with precision and safety.

Benefits of technology

Facilitates efficient, scalable, and reproducible synthesis of carbazole Schiff base derivatives with high yield and purity, reducing manual effort and environmental impact.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

A synthesis apparatus for carbazole Schiff bases, consisting of a reaction vessel with heating and stirring mechanism, reflux condenser, catalyst dosing unit, solvent recovery system, crystallization chamber, product collection container and drying unit, wherein all units are functionally interconnected to enable the automated synthesis of carbazole Schiff base derivatives by condensation reactions between carbazole derivatives and substituted aldehydes.
Need to check novelty before this filing date? Find Prior Art

Description

AREA OF INVENTION

[0001] The present invention relates to the field of medicinal chemistry and automated chemical synthesis, in particular the development of a novel synthesis device for the production of carbazole Schiff base derivatives. BACKGROUND OF THE INVENTION

[0002] Conventional laboratory methods for the synthesis of carbazole Schiff base derivatives rely on manually operated reflux and condensation apparatus. These are labor-intensive, time-consuming, and susceptible to temperature fluctuations. Separate apparatus is typically required for heating, solvent recovery, and crystallization, resulting in higher energy consumption and reduced reproducibility. Furthermore, manual handling increases exposure to hazardous chemicals and reduces yield consistency. The lack of integrated automation and in-situ monitoring limits the scalability of the process. Therefore, there is a need for a compact, automated, and energy-efficient apparatus that enables the multi-step synthesis of carbazole Schiff base derivatives with higher precision and safety. SUMMARY OF THE INVENTION

[0003] The invention relates to a novel synthesis apparatus for the automated production of carbazole Schiff base derivatives. The system comprises interconnected modules, including a reaction chamber, heating and reflux controllers, a catalyst dosing unit, a solvent management unit, a condenser, and an integrated crystallization chamber. The apparatus can perform multi-step condensation reactions between carbazole derivatives and aldehydes or ketones under precise temperature control.

[0004] The device offers a system-oriented configuration that enables the execution of multiple synthesis reaction steps under controlled conditions to obtain compounds with potential antibacterial properties. The invention focuses on the development of an integrated synthesis unit that combines heating, reflux, condensation, and crystallization in a single automated setup. The system is designed for the synthesis of carbazole Schiff base derivatives, which are known for their diverse biological applications, particularly as antibacterial agents against resistant bacterial strains.

[0005] The application area of ​​this invention further encompasses process automation, reaction optimization, and compound purification, enabling the precise control of reaction parameters such as temperature, solvent composition, and reaction time. The invention facilitates the reproducible synthesis of hydrazide intermediates and Schiff bases with consistent purity and high yield. Conventional synthesis apparatuses often require separate units for condensation, reflux, and product recovery, leading to inconsistencies, energy inefficiency, and extended reaction times. The proposed device overcomes these limitations by integrating programmable temperature control, solvent recovery, and in-situ monitoring of chemical transformations.

[0006] This device is particularly suitable for pharmaceutical and chemical laboratories that produce antibacterial compounds, enabling the efficient synthesis of carbazole-based Schiff bases with minimal manual effort. Thanks to its modular architecture, the system can be modified for the synthesis of other heterocyclic derivatives and is therefore applicable in organic, medicinal, and industrial chemistry. Through its design and automation features, the invention represents a significant advance in laboratory-scale chemical synthesis, offering an environmentally friendly, efficient, and scalable solution for the production of novel antibacterial agents.

[0007] In operation, the apparatus enables the controlled synthesis of intermediates and final Schiff base derivatives through automated mixing, reflux, and crystallization in a closed loop. The design ensures efficient solvent recycling, minimizes reagent losses, and reduces human error. Integrated sensors continuously monitor reaction conditions such as temperature, pH, and pressure, while a digital interface allows for the programming of reaction profiles. The invention guarantees high reproducibility and purity of the synthesized carbazole Schiff base derivatives and is particularly advantageous for the development of antibacterial agents on a laboratory or pilot scale. DETAILED DESCRIPTION OF THE INVENTION

[0008] The carbazole Schiff base synthesis apparatus is a compact, modular system for the controlled synthesis of heterocyclic derivatives. The apparatus consists of a main reaction vessel with a heating and stirring mechanism and a reflux condenser connected to a catalyst dosing unit. The reaction vessel contains a mixture of carbazole derivatives and aldehydes or ketones, while the heating unit maintains the desired reaction temperature by means of an adjustable thermostat.

[0009] The reflux condenser enables condensation reactions under reflux conditions by condensing vapors and returning the solvent to the reaction vessel. The catalyst dosing unit allows for the precise addition of acid or base catalysts required for the formation of imine bonds. The solvent recovery and recycling unit captures evaporated solvents, condenses them, and returns them to the reaction vessel. This ensures an environmentally friendly process with minimal solvent loss.

[0010] Reactants such as ethyl 2-(9H-carbazol-9-yl) acetate and hydrazine hydrate can be added in a controlled manner via an inlet port, forming the intermediate hydrazide. This intermediate then condenses in the same vessel with substituted aldehydes to form carbazole Schiff base derivatives. The system automatically switches between the reaction phases. Programmable software regulates the heating time, stirring speed, and reaction intervals.

[0011] A crystallization and filtration chamber receives the reaction mixture after condensation. Controlled cooling in this chamber enables the crystallization of the Schiff base derivatives, which are subsequently separated by an integrated vacuum filtration mechanism. The crystalline products are collected in a product container connected to a drying unit. There, residual solvents are removed under controlled vacuum and temperature.

[0012] A spectral monitoring interface enables in-situ monitoring using sensors that measure changes in optical properties, thus allowing real-time observation of imine formation (C=N). The system ensures uniform reaction conditions and precise synthesis control, which is crucial for obtaining high-purity products.

[0013] The device enables the synthesis of various derivatives by varying the substituted aldehydes used, such as hydroxybenzaldehyde, nitrobenzaldehyde, or chlorobenzaldehyde, resulting in derivatives with different biological properties. The integrated data acquisition system records reaction parameters and yields, thus ensuring the reproducibility of results in the laboratory.

[0014] The overall design of the instrument significantly reduces synthesis time, improves reaction consistency, and minimizes risks associated with manual handling. Thanks to its modular structure, researchers can reconfigure components depending on the reaction type, thus scaling up synthesis from laboratory to pilot scale. The instrument is constructed from chemical-resistant materials such as borosilicate glass and stainless steel, ensuring durability and compatibility with organic solvents.

[0015] In operation, the device automates the multi-step synthesis pathway from the carbazole precursor to the final Schiff base derivative. Each step—reaction, condensation, crystallization, and drying—is sequentially controlled by integrated process control software, enabling fully automated operation. This system thus represents a significant technological advancement in organic synthesis equipment and ensures high yield, safety, and environmental compatibility.

Claims

[1] A synthesis apparatus for carbazole Schiff bases, comprising a reaction vessel with heating and stirring mechanism, reflux condenser, catalyst dosing unit, solvent recovery system, crystallization chamber, product collection container and drying unit, wherein all units are functionally connected to enable the automated synthesis of carbazole Schiff base derivatives by condensation reactions between carbazole derivatives and substituted aldehydes. [2] Device according to claim 1, wherein the heating and stirring mechanism maintains a controlled temperature range between 50 °C and 120 °C with uniform stirring to ensure consistent reaction kinetics and product homogeneity. [3] Device according to claim 1, wherein the reflux condenser and the solvent recovery system operate in a closed-loop configuration to recycle solvent vapors, thereby increasing efficiency and reducing waste. [4] Device according to claim 1, wherein the crystallization chamber and the drying unit are configured to purify and isolate the final carbazole Schiff base derivatives, thus producing highly pure antibacterial compounds suitable for pharmaceutical applications.